New York Life Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
187,571
+789
| +0.4% | +$87.5K | 0.19% | 101 |
|
|
2025
Q1 | $20.9M | Sell |
186,782
-1,396
| -0.7% | -$156K | 0.21% | 98 |
|
|
2024
Q4 | $17.4M | Buy |
188,178
+1,942
| +1% | +$179K | 0.17% | 116 |
|
|
2024
Q3 | $15.6M | Sell |
186,236
-6,006
| -3% | -$504K | 0.15% | 137 |
|
|
2024
Q2 | $13.2M | Buy |
192,242
+1,965
| +1% | +$135K | 0.13% | 156 |
|
|
2024
Q1 | $13.9M | Sell |
190,277
-6,539
| -3% | -$479K | 0.14% | 142 |
|
|
2023
Q4 | $15.9M | Sell |
196,816
-27,356
| -12% | -$2.22M | 0.16% | 121 |
|
|
2023
Q3 | $16.8M | Sell |
224,172
-6,022
| -3% | -$451K | 0.18% | 110 |
|
|
2023
Q2 | $17.7M | Sell |
230,194
-2,297
| -1% | -$177K | 0.18% | 114 |
|
|
2023
Q1 | $19.3M | Sell |
232,491
-19,284
| -8% | -$1.6M | 0.21% | 105 |
|
|
2022
Q4 | $21.6M | Sell |
251,775
-1,442
| -0.6% | -$124K | 0.25% | 89 |
|
|
2022
Q3 | $15.6M | Sell |
253,217
-3,358
| -1% | -$207K | 0.19% | 119 |
|
|
2022
Q2 | $15.9M | Buy |
+256,575
| New | +$15.9M | 0.18% | 115 |
|